KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Amortizatization of Intangibles (2016 - 2025)

Inovio Pharmaceuticals' Amortizatization of Intangibles history spans 16 years, with the latest figure at -$63870.0 for Q3 2025.

  • For Q3 2025, Amortizatization of Intangibles fell 107.62% year-over-year to -$63870.0; the TTM value through Sep 2025 reached -$183248.0, down 112.13%, while the annual FY2024 figure was $1.4 million, 847.55% up from the prior year.
  • Amortizatization of Intangibles for Q3 2025 was -$63870.0 at Inovio Pharmaceuticals, down from $12617.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.0 million in Q2 2023 and bottomed at -$2.3 million in Q3 2023.
  • The 5-year median for Amortizatization of Intangibles is $130500.0 (2021), against an average of $47502.9.
  • The largest YoY upside for Amortizatization of Intangibles was 6699.16% in 2021 against a maximum downside of 1582.0% in 2021.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$2.0 million in 2021, then soared by 95.64% to -$88322.0 in 2022, then tumbled by 2455.46% to -$2.3 million in 2023, then skyrocketed by 94.13% to -$132381.0 in 2024, then surged by 51.75% to -$63870.0 in 2025.
  • Per Business Quant, the three most recent readings for INO's Amortizatization of Intangibles are -$63870.0 (Q3 2025), $12617.0 (Q2 2025), and $386.0 (Q1 2025).